Current UV Index
UV index: 0.0
Alice Springs
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0
UV index: 0.0

Click the indexes to view the minimum recommended protection

When the UV index is low, sun protection is generally not needed unless outside for extended periods

UV observations courtesy of ARPANSA

Fast facts

  • Around 36 Australians are diagnosed with Melanoma every day.
  • Australia has one of the highest rates of Melanoma in the world.
  • Approx one person dies every 5 hours from Melanoma in Australia.
  • An estimated 545 Australian women will die from melanoma THIS YEAR.
  • Tanning beds emit dangerous UV rays, increasing the risk of Melanoma.
  • Severe sunburn during childhood can DOUBLE your risk of Melanoma.
  • Melanoma is one of the most preventable forms of cancer.
  • An estimated 1230 Australian men will die from melanoma THIS YEAR.
  • Melanoma is the cancer most likely to affect 15-39 year olds.
  • Melanoma can arise in normal looking skin, a mole or freckle.
  • Melanoma, if detected/treated early, has a survival rate of nearly 100%.
  • There is no cure for melanoma that has spread throughout the body.


Our Focus

The AMRF is currently committed to funding research that meets the following criteria:

* investigating potential treatments for advanced melanoma that are:

* related to the human immune system (immunotherapy)

* low cost

* low toxicity

* for all patients

Current Sponsored Research Projects

1)  EMOTIV Melanoma Vaccine Study - a clinical trial based at the Royal Adelaide Hospital for patients with Advanced Stage III or IV, non-resectable melanoma. This study is investigating the notion of the 'timing' of vaccine treatment.  It is a follow on study from the successful VMCL trial .

2)  Immune Cycle Mathematical Analysis - a collaboration between faculties of the University of Adelaide that is delving into proposed cyclical behaviours of the human immune system.

3) Comparison of Current Advanced Melanoma Treatments - a project designed to provide patient friendly insight into the differences between current therapies on offer for advanced melanoma.

4) Long Term Survival Analysis - ongoing surveillance/analysis of the survivors of the 2000-2010 VMCL trial.

5) Timing Effect of IL-2 Therapy of Melanoma in a Mouse Model (completed - awaiting publication)

6) Timing Effect of Higher Dose IL-2 Therapy of Melanoma in a Mouse Model (completed - undergoing statistical analysis)


A Novel Approach

AMRF is endorsing the investigation into 'timing' of treatments based on the following:

Research has repeatedly shown that the immune system plays a crucial role in cancer growth, control or elimination.  A small Adelaide based group have been working for many years on a cancer treatment approach where the immune system is ‘boosted’ and toxic effects are greatly reduced.  This is being explored using more frequent but less potent treatments.

Combined with that, the identifying of ‘immune cycles’  suggests the timing of treatment may be critical in determining whether the cancer is controlled or permitted to grow.  It appears that the successful treatment of cancer may depend on delivering treatment that is accurately timed to match fluctuations in a patients own individual immune 'cycle'. It is understood that each patient’s own repeating ‘immune cycle’ appears to have small ‘windows’ where treatment appears more effective. Treatment during other times of the cycle appears to not be as effective.

This research effort is in line with our Research Vision of developing simple low-cost treatments by "thinking outside the square", rather than pursuing highly complex technology and treatments.

For further information on the immune cycle approach:

* CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?